Skip to Main Content

Author Details

Ling Liu
Lilly Research Laboratories
2003
12
9
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
32370596<i>Post-hoc</i> assessment of the immunogenicity of three antibodies reveals distinct immune stimulatory mechanisms.MAbs2020
31857683MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinoma.Mod Pathol2020
32702402A novel immunohistochemical scoring system reveals associations of C-terminal MET, ectodomain shedding, and loss of E-cadherin with poor prognosis in oral squamous cell carcinoma.Hum Pathol2020
32300899Development of a FRET-Based Assay for Analysis of mAbs Internalization and Processing by Dendritic Cells in Preclinical Immunogenicity Risk Assessment.AAPS J2020
29188469MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping.Invest New Drugs2018
28406969Reconstruction of 3D structures of MET antibodies from electron microscopy 2D class averages.PLoS One2017
27143947Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A.J Inflamm Res2016
25039923Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET).Histopathology2014
25231402LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth.Clin Cancer Res2014
17010592The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.Curr Opin Immunol2006
15118535Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling.Crit Care Med2004
12855566Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20.Blood2003
  • 1 - 12 of 12

Recommended Authors

Zaid Taha
Ottawa Hospital Research Institute, University of Ottawa
Career Start Year 2018
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
John F Reilly
Goldfinch Bio Inc.
Career Start Year 2007
Number of shared co-authors 0
Moutih Rafei
Universite de Montreal
Career Start Year 2007
Number of shared co-authors 0
Aaron M Ring
Yale University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Andrew Boudreau
Career Start Year 2005
Number of shared co-authors 0
Ningyan Zhang
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Vineet Gupta
Purdue University
Career Start Year 1999
Number of shared co-authors 1
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Arvind Rajpal
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 2
Yunkai Yu
National Cancer Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 0
Yeup Yoon
Sungkyunkwan University
Career Start Year 1995
Number of shared co-authors 0
Manish J Butte
University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 0
Zhiqiang An
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Terrance G Johns
Telethon Kids Institute
Career Start Year 1990
Number of shared co-authors 0
Rosalba Salcedo
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
Timothy A Lewis
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 0
Renata Pasqualini
Rutgers Cancer Institute of New Jersey
Career Start Year 1988
Number of shared co-authors 0
Jennifer Soto
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 0
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Wadih Arap
Rutgers Cancer Institute of New Jersey
Career Start Year 1983
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 0
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 0

Collaborators

Wei Zeng
Lilly Research Laboratories
Co-authored papers 10
Jirong Lu
Lilly Research Laboratories
Co-authored papers 5
Christine Humblet
Lilly Research Laboratories
Co-authored papers 1
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Qi Chen
Lilly Research Laboratories
Co-authored papers 1
Michael Vieth
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Co-authored papers 1
David E Timm
Lilly Research Laboratories
Co-authored papers 1
Ilan E Chemmama
University of California san francisco
Co-authored papers 1
Dina Schneidman-Duhovny
The Hebrew University of Jerusalem
Co-authored papers 1
Release 1.2